Viscogliosi Brothers, LLC (VB), headquartered in New York City, specializes in venture capital, private equity and merchant banking for the neuromusculoskeletal industry.
Founded by Anthony, John and Marc Viscogliosi in 1999, the firm creates, builds, operates and finances companies founded on surgeon development innovation to address unmet clinical needs uniquely focused on "life changing" neuromusculoskeletal technologies. VB principals have participated in more than 200 transactions, have invested in more than 20 companies and have formed nine partnerships.
More than $1.5 billion in exit value achieved by companies that VB, its affiliates, and/or its partnerships have invested in.
Through its portfolio companies VB has defined five new orthopedic industry categories.
Its investments have helped commercialize more than 75 med-tech devices, including ten number one orthopedic technologies.
VB invested in or created market leading businesses.
VB portfolio companies have sold products in more than 70 countries.
VB focuses on supporting growth by providing clinically-proven data driven product innovations. VB practices its "More…Better…First!" philosophy through trying to learn MORE information, synthesis it into BETTER quality intelligence and create action FIRST. The firm focuses on accessing top research, understanding the competitive landscape and market needs of the neuromusculoskeletal/orthopedic industry and developing products that address those needs as rapid as possible.
VB invests in technologies whose applications benefit patients and the healthcare system by improving care, reducing costs, and expanding the availability of care. With enhanced data, VB attempts to identify the technologies that best satisfy these criteria and works to transform them into successful medical breakthroughs that enable patients to regain active lifestyles.